Idarucizumab: The Antidote for Reversal of Dabigatran
- PMID: 26700008
- DOI: 10.1161/CIRCULATIONAHA.115.019628
Idarucizumab: The Antidote for Reversal of Dabigatran
Keywords: anticoagulant; dabigatran; hemorrhage; idarucizumab.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical